Report Detail

Pharma & Healthcare Global Receptor Tyrosine Protein Kinase ERBB 3 Market Professional Survey Report 2019

  • RnM2954733
  • |
  • 16 February, 2019
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Receptor Tyrosine Protein Kinase ERBB 3 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Receptor Tyrosine Protein Kinase ERBB 3 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Receptor Tyrosine Protein Kinase ERBB 3 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Receptor Tyrosine Protein Kinase ERBB 3 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Receptor Tyrosine Protein Kinase ERBB 3 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others

Segment by Application
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Receptor Tyrosine Protein Kinase ERBB 3

      • 1.1 Definition of Receptor Tyrosine Protein Kinase ERBB 3
      • 1.2 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Type
        • 1.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 BA-0702
        • 1.2.3 CDX-3379
        • 1.2.4 Elgemtumab
        • 1.2.5 ETBX-031
        • 1.2.6 Others
      • 1.3 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Applications
        • 1.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Non-Small Cell Carcinoma
        • 1.3.3 Solid Tumor
        • 1.3.4 Melanoma
        • 1.3.5 Colorectal Cancer
        • 1.3.6 Others
      • 1.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Overall Market
        • 1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2014-2025)
        • 1.4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Production (2014-2025)
        • 1.4.3 North America Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2014-2025)
        • 1.4.4 Europe Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2014-2025)
        • 1.4.5 China Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2014-2025)
        • 1.4.6 Japan Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2014-2025)
        • 1.4.8 India Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase ERBB 3
      • 2.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 3
      • 2.4 Industry Chain Structure of Receptor Tyrosine Protein Kinase ERBB 3

      3 Development and Manufacturing Plants Analysis of Receptor Tyrosine Protein Kinase ERBB 3

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Receptor Tyrosine Protein Kinase ERBB 3
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Receptor Tyrosine Protein Kinase ERBB 3 Production and Capacity Analysis
      • 4.2 Receptor Tyrosine Protein Kinase ERBB 3 Revenue Analysis
      • 4.3 Receptor Tyrosine Protein Kinase ERBB 3 Price Analysis
      • 4.4 Market Concentration Degree

      5 Receptor Tyrosine Protein Kinase ERBB 3 Regional Market Analysis

      • 5.1 Receptor Tyrosine Protein Kinase ERBB 3 Production by Regions
        • 5.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Production by Regions
        • 5.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Regions
      • 5.2 Receptor Tyrosine Protein Kinase ERBB 3 Consumption by Regions
      • 5.3 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
        • 5.3.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Production
        • 5.3.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Receptor Tyrosine Protein Kinase ERBB 3 Import and Export
      • 5.4 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
        • 5.4.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Production
        • 5.4.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Receptor Tyrosine Protein Kinase ERBB 3 Import and Export
      • 5.5 China Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
        • 5.5.1 China Receptor Tyrosine Protein Kinase ERBB 3 Production
        • 5.5.2 China Receptor Tyrosine Protein Kinase ERBB 3 Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Receptor Tyrosine Protein Kinase ERBB 3 Import and Export
      • 5.6 Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
        • 5.6.1 Japan Receptor Tyrosine Protein Kinase ERBB 3 Production
        • 5.6.2 Japan Receptor Tyrosine Protein Kinase ERBB 3 Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Receptor Tyrosine Protein Kinase ERBB 3 Import and Export
      • 5.7 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
        • 5.7.1 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Production
        • 5.7.2 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Import and Export
      • 5.8 India Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
        • 5.8.1 India Receptor Tyrosine Protein Kinase ERBB 3 Production
        • 5.8.2 India Receptor Tyrosine Protein Kinase ERBB 3 Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Receptor Tyrosine Protein Kinase ERBB 3 Import and Export

      6 Receptor Tyrosine Protein Kinase ERBB 3 Segment Market Analysis (by Type)

      • 6.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Production by Type
      • 6.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type
      • 6.3 Receptor Tyrosine Protein Kinase ERBB 3 Price by Type

      7 Receptor Tyrosine Protein Kinase ERBB 3 Segment Market Analysis (by Application)

      • 7.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Consumption by Application
      • 7.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Consumption Market Share by Application (2014-2019)

      8 Receptor Tyrosine Protein Kinase ERBB 3 Major Manufacturers Analysis

      • 8.1 AstraZeneca Plc
        • 8.1.1 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
        • 8.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 AVEO Pharmaceuticals, Inc.
        • 8.2.1 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.2.2 AVEO Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Etubics Corporation
        • 8.3.1 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.3.2 Etubics Corporation Product Introduction, Application and Specification
        • 8.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 F. Hoffmann-La Roche Ltd.
        • 8.4.1 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.4.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
        • 8.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 GamaMabs Pharma S.A.
        • 8.5.1 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.5.2 GamaMabs Pharma S.A. Product Introduction, Application and Specification
        • 8.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 GlaxoSmithKline Plc
        • 8.6.1 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.6.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
        • 8.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Hanmi Pharmaceuticals, Co. Ltd.
        • 8.7.1 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.7.2 Hanmi Pharmaceuticals, Co. Ltd. Product Introduction, Application and Specification
        • 8.7.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 ImmunoGen, Inc.
        • 8.8.1 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.8.2 ImmunoGen, Inc. Product Introduction, Application and Specification
        • 8.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Kolltan Pharmaceuticals, Inc.
        • 8.9.1 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.9.2 Kolltan Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Merrimack Pharmaceuticals, Inc.
        • 8.10.1 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Production Sites and Area Served
        • 8.10.2 Merrimack Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Merus B.V.
      • 8.12 Novartis AG
      • 8.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
      • 8.14 Sihuan Pharmaceutical Holdings Group Ltd.
      • 8.15 Sorrento Therapeutics, Inc.
      • 8.16 Symphogen A/S
      • 8.17 Takis S.r.l.

      9 Development Trend of Analysis of Receptor Tyrosine Protein Kinase ERBB 3 Market

      • 9.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Trend Analysis
        • 9.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Receptor Tyrosine Protein Kinase ERBB 3 Regional Market Trend
        • 9.2.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Forecast 2019-2025
        • 9.2.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Forecast 2019-2025
        • 9.2.3 China Receptor Tyrosine Protein Kinase ERBB 3 Forecast 2019-2025
        • 9.2.4 Japan Receptor Tyrosine Protein Kinase ERBB 3 Forecast 2019-2025
        • 9.2.5 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Forecast 2019-2025
        • 9.2.6 India Receptor Tyrosine Protein Kinase ERBB 3 Forecast 2019-2025
      • 9.3 Receptor Tyrosine Protein Kinase ERBB 3 Market Trend (Product Type)
      • 9.4 Receptor Tyrosine Protein Kinase ERBB 3 Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Receptor Tyrosine Protein Kinase ERBB 3 Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Receptor Tyrosine Protein Kinase ERBB 3 . Industry analysis & Market Report on Receptor Tyrosine Protein Kinase ERBB 3 is a syndicated market report, published as Global Receptor Tyrosine Protein Kinase ERBB 3 Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Receptor Tyrosine Protein Kinase ERBB 3 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,754.50
        4,131.75
        5,509.00
        3,234.00
        4,851.00
        6,468.00
        549,115.00
        823,672.50
        1,098,230.00
        291,550.00
        437,325.00
        583,100.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report